THYROCARE TECHNOLOGIES
Back to Cashflow Statement
|
THYROCARE TECHNOLOGIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-130 Cr | ₹-85 Cr | ₹-86 Cr | ₹-89 Cr | ₹-62 Cr |
What is the latest Cash Flow from Financing Activities ratio of THYROCARE TECHNOLOGIES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-130 Cr |
| Mar2024 | ₹-85 Cr |
| Mar2023 | ₹-86 Cr |
| Mar2022 | ₹-89 Cr |
| Mar2021 | ₹-62 Cr |
How is Cash Flow from Financing Activities of THYROCARE TECHNOLOGIES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-130 Cr | Negative | |
| Mar2024 | ₹-85 Cr | Negative | |
| Mar2023 | ₹-86 Cr | Negative | |
| Mar2022 | ₹-89 Cr | Negative | |
| Mar2021 | ₹-62 Cr | - | |
Compare Cash Flow from Financing Activities of peers of THYROCARE TECHNOLOGIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| THYROCARE TECHNOLOGIES | ₹6,376.8 Cr | 1.4% | 11.2% | 34.1% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹109,840.0 Cr | -1.1% | 1.2% | 10.8% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹96,657.5 Cr | -0.6% | 1.9% | -5.8% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹69,709.1 Cr | -0.5% | 13.5% | 42.9% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹36,093.2 Cr | -0.2% | 7.9% | -1% | Stock Analytics | |
| GLOBAL HEALTH | ₹30,048.2 Cr | 1.1% | 13.5% | -5.6% | Stock Analytics | |
THYROCARE TECHNOLOGIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| THYROCARE TECHNOLOGIES | 1.4% |
11.2% |
34.1% |
| SENSEX | -1% |
2.2% |
-3.6% |
You may also like the below Video Courses